Introduced
Underlined text would be added to current law. Struck-through text would be removed.
| 89R15191 CJD-F | ||
| By: Perry | S.B. No. 1867 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to the addition of certain substances to Penalty Group 2 of | |
| the Texas Controlled Substances Act. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. Section 481.103(a), Health and Safety Code, is | |
| amended to read as follows: | |
| (a) Penalty Group 2 consists of: | |
| (1) any quantity of the following hallucinogenic | |
| substances, their salts, isomers, and salts of isomers, unless | |
| specifically excepted, if the existence of these salts, isomers, | |
| and salts of isomers is possible within the specific chemical | |
| designation: | |
| 5-(2-aminopropyl)benzofuran (5-APB); | |
| 6-(2-aminopropyl)benzofuran (6-APB); | |
| 5-(2-aminopropyl)-2,3-dihydrobenzofuran | |
| (5-APDB); | |
| 6-(2-aminopropyl)-2,3-dihydrobenzofuran | |
| (6-APDB); | |
| 5-(2-aminopropyl)indole (5-IT,5-API); | |
| 6-(2-aminopropyl)indole (6-IT,6-API); | |
| 1-(benzofuran-5-yl)-N-methylpropan-2-amine | |
| (5-MAPB); | |
| 1-(benzofuran-6-yl)-N-methylpropan-2-amine | |
| (6-MAPB); | |
| Benzothiophenylcyclohexylpiperidine (BTCP); | |
| 8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran- | |
| 4-ethanamine (trade or other name: Bromo-DragonFLY); | |
| Desoxypipradrol (2-benzhydrylpiperidine); | |
| 2, 5-dimethoxyamphetamine (some trade or other | |
| names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA); | |
| Diphenylprolinol (diphenyl(pyrrolidin-2-yl) | |
| methanol, D2PM); | |
| Dronabinol (synthetic) in sesame oil and | |
| encapsulated in a soft gelatin capsule in a U.S. Food and Drug | |
| Administration approved drug product (some trade or other names for | |
| Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9- | |
| trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9- | |
| (trans)- tetrahydrocannabinol); | |
| Ethylamine Analog of Phencyclidine (some trade or | |
| other names: N-ethyl-1-phenylcyclohexylamine, (1- | |
| phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, | |
| cyclohexamine, PCE); | |
| 2-ethylamino-2-(3-methoxyphenyl)cyclohexanone | |
| (trade or other name: methoxetamine); | |
| Ibogaine (some trade or other names: 7-Ethyl-6, | |
| 6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H- | |
| pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.); | |
| 5-iodo-2-aminoindane (5-IAI); | |
| Mescaline; | |
| 5-methoxy-3, 4-methylenedioxy amphetamine; | |
| 4-methoxyamphetamine (some trade or other | |
| names: 4-methoxy-alpha-methylphenethylamine; | |
| paramethoxyamphetamine; PMA); | |
| 4-methoxymethamphetamine (PMMA); | |
| 2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone | |
| (some trade and other names: 2-MeO-ketamine; methoxyketamine); | |
| 1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP, | |
| PPMP); | |
| 4-methyl-2, 5-dimethoxyamphetamine (some trade | |
| and other names: 4-methyl-2, 5-dimethoxy-alpha- | |
| methylphenethylamine; "DOM"; "STP"); | |
| 3,4-methylenedioxy methamphetamine (MDMA, MDM); | |
| 3,4-methylenedioxy amphetamine; | |
| 3,4-methylenedioxy N-ethylamphetamine (Also | |
| known as N-ethyl MDA); | |
| 5,6-methylenedioxy-2-aminoindane (MDAI); | |
| Nabilone (Another name for nabilone: (+)-trans- | |
| 3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6, | |
| 6-dimethyl-9H-dibenzo[b,d] pyran-9-one; | |
| N-benzylpiperazine (some trade or other | |
| names: BZP; 1-benzylpiperazine); | |
| N-ethyl-3-piperidyl benzilate; | |
| N-hydroxy-3,4-methylenedioxyamphetamine (Also | |
| known as N-hydroxy MDA); | |
| 4-methylaminorex; | |
| N-methyl-3-piperidyl benzilate; | |
| Parahexyl (some trade or other names: 3-Hexyl-1- | |
| hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d] | |
| pyran; Synhexyl); | |
| 1-Phenylcyclohexylamine; | |
| 1-Piperidinocyclohexanecarbonitrile (PCC); | |
| Pyrrolidine Analog of Phencyclidine (some trade | |
| or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP); | |
| Tetrahydrocannabinols, other than marihuana, and | |
| synthetic equivalents of the substances contained in the plant, or | |
| in the resinous extractives of Cannabis, or synthetic substances, | |
| derivatives, and their isomers with similar chemical structure and | |
| pharmacological activity such as: | |
| delta-1 cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-6 cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-3, 4 cis or trans | |
| tetrahydrocannabinol, and its optical isomers; [ |
|
| delta-5, cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-6a, cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-7, cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-7a, cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-8, cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-9, cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-10, cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-10a, cis or trans | |
| tetrahydrocannabinol, and their optical isomers; | |
| delta-11, cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-11-Hydroxy-tetrahydrocannabinol; | |
| exo-tetrahydrocannabinol; | |
| 1-pentyl-3-(1-naphthoyl) indole (JWH-018); | |
| 1-butyl-3-(1-naphthoyl) indole (JWH-073); | |
| 1-pentyl-3-(4-methoxynaphthoyl) indole | |
| (14-JWH-200); | |
| 1-pentyl-3-(2-methoxynaphthoyl) indole | |
| (JWH-250); | |
| 1-pentyl-3-(4-chloronaphthoyl) indole | |
| (JWH-398); | |
| 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3- | |
| hydroxycyclohexyl]-phenol (CP-47,497); | |
| (6aR,10aR)-9-(hydroxymethyl)-6,6- | |
| dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo | |
| [c]chromen-1-ol (HU-210); | |
| (6a,10a)-9-(hydroxymethyl)-6,6- | |
| dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo | |
| [c]chromen-1-ol (HU-211); | |
| tetrahydrocannabivarins, including delta-8 | |
| tetrahydrocannabivarin; | |
| metabolites of tetrahydrocannabinol, | |
| including 11-hydroxy-tetrahydrocannabinol, | |
| 3-hydroxy-tetrahydrocannabinol, and | |
| 7-hydroxy-tetrahydrocannabinol; | |
| hexahydrocannabiphorol-o-ester; | |
| hydrogenated forms of tetrahydrocannabinol, | |
| including hexahydrocannabinol, hexahydrocannabiphorol, and | |
| hexahydrocannabihexol; | |
| hydrogenated forms of hexahydrocannabinol | |
| (HHC), including 8-hydroxyhexahydrocannabinol and | |
| 10-hydroxyhexahydrocannabinol; | |
| ester forms of tetrahydrocannabinol, | |
| including delta-8 THC-O-acetate, delta-9 THC-O-acetate, and | |
| hexahydrocannabinol-O-acetate; | |
| tetrahydrocannabinols with alkyl chain of | |
| four or more carbon atoms, including tetrahydrocannabiphorols | |
| (THCP), tetrahydrocannabioctyls, tetrahydrocannabihexols (THCH), | |
| tetrahydrocannabidiol (THC-JD), and tetrahydrocannabutols; | |
| tetrahydrocannabinol acetate (THC-O); | |
| tetrahydrocannabinol methyl ester; | |
| N-(1-Amino-1-methyl-ethyl)-5-fluoropen | |
| tyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (XRL-11 &15); | |
| N-(1-Amino-1-methyl-ethyl)-5-fluoropen | |
| tyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (UR-144); | |
| N-(1-Amino-1-methyl-ethyl)-5-fluoropen | |
| tyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (FUB-144); | |
| N-(1-Amino-1-methyl-ethyl)-5-fluoropen | |
| tyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (AMB-FUBINACA); | |
| (3-[(1R,4R)-Isopropyl-2-methyl-1,3-benzo | |
| dioxol-5-yl]-N-(2,4-dimethyl-3-methylbenzoyl)-N-methyl-1,2,3,4- | |
| tetrahydroisoquinolin-6-amine) (THJ-220); | |
| (3-[(1R,4R)-Isopropyl-2-methyl-1,3-benzo | |
| dioxol-5-yl]-N-(2,4-dimethyl-3-methylbenzoyl)-N-methyl-1,2,3,4- | |
| tetrahydroisoquinolin-6-amine) (RCS-4); | |
| Cannabicycloheptanone; or | |
| compounds of these structures, regardless of | |
| numerical designation of atomic positions, since nomenclature of | |
| these substances is not internationally standardized; | |
| Thiophene Analog of Phencyclidine (some trade or | |
| other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl | |
| Analog of Phencyclidine; TPCP, TCP); | |
| 1-pyrrolidine (some trade or other name: TCPy); | |
| 1-(3-trifluoromethylphenyl)piperazine (trade or | |
| other name: TFMPP); and | |
| 3,4,5-trimethoxy amphetamine; | |
| (2) Phenylacetone (some trade or other | |
| names: Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl | |
| ketone); | |
| (3) unless specifically excepted or unless listed in | |
| another Penalty Group, a material, compound, mixture, or | |
| preparation that contains any quantity of the following substances | |
| having a potential for abuse associated with a depressant or | |
| stimulant effect on the central nervous system: | |
| Aminorex (some trade or other names: aminoxaphen; | |
| 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5- | |
| phenyl-2-oxazolamine); | |
| Amphetamine, its salts, optical isomers, and | |
| salts of optical isomers; | |
| Cathinone (some trade or other names: 2-amino-1- | |
| phenyl-1-propanone, alpha-aminopropiophenone, 2- | |
| aminopropiophenone); | |
| Etaqualone and its salts; | |
| Etorphine Hydrochloride; | |
| Fenethylline and its salts; | |
| Lisdexamfetamine, including its salts, isomers, | |
| and salts of isomers; | |
| Mecloqualone and its salts; | |
| Methaqualone and its salts; | |
| Methcathinone (some trade or other names: 2- | |
| methylamino-propiophenone; alpha-(methylamino)propriophenone; | |
| 2-(methylamino)-1-phenylpropan-1-one; alpha-N- | |
| methylaminopropriophenone; monomethylpropion; ephedrone, N- | |
| methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR | |
| 1431); | |
| N-Ethylamphetamine, its salts, optical isomers, | |
| and salts of optical isomers; and | |
| N,N-dimethylamphetamine (some trade or other | |
| names: N,N,alpha-trimethylbenzeneethanamine; | |
| N,N,alpha-trimethylphenethylamine), its salts, optical isomers, | |
| and salts of optical isomers; | |
| (4) any compound structurally derived from | |
| 2-aminopropanal by substitution at the 1-position with any | |
| monocyclic or fused-polycyclic ring system, including: | |
| (A) compounds further modified by: | |
| (i) substitution in the ring system to any | |
| extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or | |
| halide substituents), whether or not further substituted in the | |
| ring system by other substituents; | |
| (ii) substitution at the 3-position with an | |
| alkyl substituent; or | |
| (iii) substitution at the 2-amino nitrogen | |
| atom with alkyl, benzyl, dialkyl, or methoxybenzyl groups, or | |
| inclusion of the 2-amino nitrogen atom in a cyclic structure; and | |
| (B) by example, compounds such as: | |
| 4-Methylmethcathinone (Also known as | |
| Mephedrone); | |
| 3,4-Dimethylmethcathinone (Also known as | |
| 3,4-DMMC); | |
| 3-Fluoromethcathinone (Also known as 3-FMC); | |
| 4-Fluoromethcathinone (Also known as | |
| Flephedrone); | |
| 3,4-Methylenedioxy-N-methylcathinone (Also | |
| known as Methylone); | |
| 3,4-Methylenedioxypyrovalerone (Also known | |
| as MDPV); | |
| alpha-Pyrrolidinopentiophenone (Also known | |
| as alpha-PVP); | |
| Naphthylpyrovalerone (Also known as | |
| Naphyrone); | |
| alpha-Methylamino-valerophenone (Also known | |
| as Pentedrone); | |
| beta-Keto-N-methylbenzodioxolylpropylamine | |
| (Also known as Butylone); | |
| beta-Keto-N-methylbenzodioxolylpentanamine | |
| (Also known as Pentylone); | |
| beta-Keto-Ethylbenzodioxolylbutanamine | |
| (Also known as Eutylone); and | |
| 3,4-methylenedioxy-N-ethylcathinone (Also | |
| known as Ethylone); | |
| (5) any compound structurally derived from tryptamine | |
| (3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine: | |
| (A) by modification in any of the following ways: | |
| (i) by substitution at the amine nitrogen | |
| atom of the sidechain to any extent with alkyl or alkenyl groups or | |
| by inclusion of the amine nitrogen atom of the side chain (and no | |
| other atoms of the side chain) in a cyclic structure; | |
| (ii) by substitution at the carbon atom | |
| adjacent to the nitrogen atom of the side chain (alpha-position) | |
| with an alkyl or alkenyl group; | |
| (iii) by substitution in the 6-membered | |
| ring to any extent with alkyl, alkoxy, haloalkyl, thioaklyl, | |
| alkylenedioxy, or halide substituents; or | |
| (iv) by substitution at the 2-position of | |
| the tryptamine ring system with an alkyl substituent; and | |
| (B) including: | |
| (i) ethers and esters of the controlled | |
| substances listed in this subdivision; and | |
| (ii) by example, compounds such as: | |
| alpha-ethyltryptamine; | |
| alpha-methyltryptamine; | |
| Bufotenine (some trade and other names: | |
| 3-(beta-Dimethylaminoethyl)-5-hydroxyindole; | |
| 3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin; | |
| 5-hydroxy-N, N- dimethyltryptamine; mappine); | |
| Diethyltryptamine (some trade and | |
| other names: N, N-Diethyltryptamine, DET); | |
| Dimethyltryptamine (trade or other | |
| name: DMT); | |
| 5-methoxy-N, N-diisopropyltryptamine | |
| (5-MeO-DiPT); | |
| O-Acetylpsilocin (Trade or other name: | |
| 4-Aco-DMT); | |
| Psilocin; and | |
| Psilocybin; | |
| (6) 2,5-Dimethoxyphenethylamine and any compound | |
| structurally derived from 2,5-Dimethoxyphenethylamine by | |
| substitution at the 4-position of the phenyl ring to any extent | |
| (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide | |
| substituents), including, by example, compounds such as: | |
| 4-Bromo-2,5-dimethoxyphenethylamine (trade or | |
| other name: 2C-B); | |
| 4-Chloro-2,5-dimethoxyphenethylamine (trade or | |
| other name: 2C-C); | |
| 2,5-Dimethoxy-4-methylphenethylamine (trade or | |
| other name: 2C-D); | |
| 4-Ethyl-2,5-dimethoxyphenethylamine (trade or | |
| other name: 2C-E); | |
| 4-Iodo-2,5-dimethoxyphenethylamine (trade or | |
| other name: 2C-I); | |
| 2,5-Dimethoxy-4-nitrophenethylamine (trade or | |
| other name: 2C-N); | |
| 2,5-Dimethoxy-4-(n)-propylphenethylamine (trade | |
| or other name: 2C-P); | |
| 4-Ethylthio-2,5-dimethoxyphenethylamine (trade | |
| or other name: 2C-T-2); | |
| 4-Isopropylthio-2,5-dimethoxyphenethylamine | |
| (trade or other name: 2C-T-4); and | |
| 2,5-Dimethoxy-4-(n)-propylthiophenethylamine | |
| (trade or other name: 2C-T-7); and | |
| (7) 2,5-Dimethoxyamphetamine and any compound | |
| structurally derived from 2,5-Dimethoxyamphetamine by substitution | |
| at the 4-position of the phenyl ring to any extent (including alkyl, | |
| alkoxy, alkylenedioxy, haloalkyl, or halide substituents), | |
| including, by example, compounds such as: | |
| 4-Ethylthio-2,5-dimethoxyamphetamine (trade or | |
| other name: Aleph-2); | |
| 4-Isopropylthio-2,5-dimethoxyamphetamine (trade | |
| or other name: Aleph-4); | |
| 4-Bromo-2,5-dimethoxyamphetamine (trade or other | |
| name: DOB); | |
| 4-Chloro-2,5-dimethoxyamphetamine (trade or | |
| other name: DOC); | |
| 2,5-Dimethoxy-4-ethylamphetamine (trade or other | |
| name: DOET); | |
| 4-Iodo-2,5-dimethoxyamphetamine (trade or other | |
| name: DOI); | |
| 2,5-Dimethoxy-4-methylamphetamine (trade or | |
| other name: DOM); | |
| 2,5-Dimethoxy-4-nitroamphetamine (trade or other | |
| name: DON); | |
| 4-Isopropyl-2,5-dimethoxyamphetamine (trade or | |
| other name: DOIP); and | |
| 2,5-Dimethoxy-4-(n)-propylamphetamine (trade or | |
| other name: DOPR). | |
| SECTION 2. The change in law made by this Act applies only | |
| to an offense committed on or after the effective date of this | |
| Act. An offense committed before the effective date of this Act is | |
| governed by the law in effect on the date the offense was committed, | |
| and the former law is continued in effect for that purpose. For | |
| purposes of this section, an offense was committed before the | |
| effective date of this Act if any element of the offense occurred | |
| before that date. | |
| SECTION 3. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.